These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17909044)

  • 41. Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption.
    Wang Y; Zhou Y; Zheng Z; Li J; Yan Y; Wu W
    Cell Death Dis; 2018 Nov; 9(11):1134. PubMed ID: 30429459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Nishimura M; Ueda N; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Feb; 13(2):217-22. PubMed ID: 15643501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.
    Mozzetti S; Ferlini C; Concolino P; Filippetti F; Raspaglio G; Prislei S; Gallo D; Martinelli E; Ranelletti FO; Ferrandina G; Scambia G
    Clin Cancer Res; 2005 Jan; 11(1):298-305. PubMed ID: 15671559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells].
    Cheng XD; Cai SX; Zhao HJ; Li WJ; Tong WC
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):389-91. PubMed ID: 18359697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of protein modulation by the synthetic retinoid CD437 in lung carcinoma cells using high throughput immunoblotting.
    Kim HJ; Lotan R
    Int J Oncol; 2005 Feb; 26(2):483-91. PubMed ID: 15645134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry.
    Verdier-Pinard P; Wang F; Burd B; Angeletti RH; Horwitz SB; Orr GA
    Biochemistry; 2003 Oct; 42(41):12019-27. PubMed ID: 14556633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [RNA interference silencing excision repair cross-complementing 1 gene and affecting cisplatin sensitivity on lung cancer cell lines].
    Shang XB; Yu ZT; Tang P; Zhang XZ
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2799-802. PubMed ID: 19080461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Taxol resistance among the different histological subtypes of ovarian cancer may be associated with the expression of class III beta-tubulin.
    Umezu T; Shibata K; Kajiyama H; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Gynecol Pathol; 2008 Apr; 27(2):207-12. PubMed ID: 18317222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
    Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
    Huffman KE; Corey DR
    Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deleted in pancreatic carcinoma locus 4/Smad4 participates in the regulation of apoptosis by affecting the Bcl-2/Bax balance in non-small cell lung cancer.
    Ke Z; Zhang X; Ma L; Wang L
    Hum Pathol; 2008 Oct; 39(10):1438-45. PubMed ID: 18620728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a novel putative non-coding RNA involved in proliferation arrest of a non-small cell lung carcinoma cell line treated with an original chemical substance, methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate.
    Jacquot C; Carbonnelle D; Tomasoni C; Papaconstadinou A; Roussis V; Roussakis C
    Int J Oncol; 2004 Aug; 25(2):519-27. PubMed ID: 15254752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of beta-tubulin mRNA and protein levels in 12 human cancer cell lines.
    Hiser L; Aggarwal A; Young R; Frankfurter A; Spano A; Correia JJ; Lobert S
    Cell Motil Cytoskeleton; 2006 Jan; 63(1):41-52. PubMed ID: 16362954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
    Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
    Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol.
    Kavallaris M; Burkhart CA; Horwitz SB
    Br J Cancer; 1999 Jun; 80(7):1020-5. PubMed ID: 10362110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
    Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A
    J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulation of β-tubulin isotypes by micro-RNA 100 in MCF7 breast cancer cells.
    Lobert S; Jefferson B; Morris K
    Cytoskeleton (Hoboken); 2011 Jun; 68(6):355-62. PubMed ID: 21634028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Class III beta-tubulin in human development and cancer.
    Katsetos CD; Herman MM; Mörk SJ
    Cell Motil Cytoskeleton; 2003 Jun; 55(2):77-96. PubMed ID: 12740870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A; Sørensen JB
    Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.